A Muller

Summary

Affiliation: University of Antwerp
Country: Belgium

Publications

  1. ncbi European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe, 1998-2005
    A Muller
    Vaccine and Infectious Disease Institute VIDI, University of Antwerp, Belgium
    Euro Surveill 12:E071011.1. 2007
  2. ncbi Drug utilization 75% (DU75%) in 17 European hospitals (2000-2005): results from the ESAC-2 Hospital Care Sub Project
    Peter Zarb
    European Surveillance of Antimicrobial Consumption, University of Antwerp, Vaccine and Infectious Disease Institute, Antwerp, Belgium
    Curr Clin Pharmacol 6:62-70. 2011
  3. doi Determinants of between-country differences in ambulatory antibiotic use and antibiotic resistance in Europe: a longitudinal observational study
    A Blommaert
    Centre for Health Economic Research and Modelling Infectious Diseases CHERMID, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 69:535-47. 2014
  4. ncbi Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae
    A Muller
    Service d Hygiène Hospitalière et d Épidémiologie Moléculaire, Centre Hospitalier Universitaire Jean Minjoz, Besancon, France
    J Antimicrob Chemother 54:173-7. 2004
  5. ncbi MRSA incidence as an indicator of infection control practices: do the results reflect the reality?
    D Talon
    J Hosp Infect 57:265-6. 2004
  6. ncbi [Surveillance of antimicrobial resistance and antimicrobial use in a university-affiliated hospital: implementation of a computerized system]
    A Muller
    Service d Hygiène Hospitalière et d Épidémiologie Moléculaire, Centre Hospitalier Universitaire Jean Minjoz, 25030 Besancon, France
    Pathol Biol (Paris) 54:112-7. 2006
  7. ncbi [Are isolation measures needed in the hospital management of Acinetobacter baumannii colonizations-infections?]
    H Gbaguidi Haore
    Service d Hygiène Hospitalière et d Épidémiologie Moléculaire, Centre Hospitalier Universitaire Jean Minjoz, 2, Boulevard Fleming, 25030 Besancon Cedex, France
    Med Mal Infect 36:201-6. 2006

Collaborators

Detail Information

Publications7

  1. ncbi European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe, 1998-2005
    A Muller
    Vaccine and Infectious Disease Institute VIDI, University of Antwerp, Belgium
    Euro Surveill 12:E071011.1. 2007
  2. ncbi Drug utilization 75% (DU75%) in 17 European hospitals (2000-2005): results from the ESAC-2 Hospital Care Sub Project
    Peter Zarb
    European Surveillance of Antimicrobial Consumption, University of Antwerp, Vaccine and Infectious Disease Institute, Antwerp, Belgium
    Curr Clin Pharmacol 6:62-70. 2011
    ..The number of drugs within DU75% was identified as another quality indicator. Thus, aspiring to decrease the consumption of overused drug classes should be set by the hospitals as a quality indicator on prescribing patterns...
  3. doi Determinants of between-country differences in ambulatory antibiotic use and antibiotic resistance in Europe: a longitudinal observational study
    A Blommaert
    Centre for Health Economic Research and Modelling Infectious Diseases CHERMID, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 69:535-47. 2014
    ..To identify key determinants explaining country-year variations in antibiotic use and resistance...
  4. ncbi Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae
    A Muller
    Service d Hygiène Hospitalière et d Épidémiologie Moléculaire, Centre Hospitalier Universitaire Jean Minjoz, Besancon, France
    J Antimicrob Chemother 54:173-7. 2004
    ..To investigate the potential correlation between the use of extended-spectrum cephalosporins (ESCs) and resistance to this antibiotic class among clinical isolates of Enterobacter cloacae in a university-affiliated hospital...
  5. ncbi MRSA incidence as an indicator of infection control practices: do the results reflect the reality?
    D Talon
    J Hosp Infect 57:265-6. 2004
  6. ncbi [Surveillance of antimicrobial resistance and antimicrobial use in a university-affiliated hospital: implementation of a computerized system]
    A Muller
    Service d Hygiène Hospitalière et d Épidémiologie Moléculaire, Centre Hospitalier Universitaire Jean Minjoz, 25030 Besancon, France
    Pathol Biol (Paris) 54:112-7. 2006
    ..The current guidelines for the control of antimicrobial resistance in hospitals recommend the implementation of a surveillance system of antimicrobial use and antimicrobial resistance data...
  7. ncbi [Are isolation measures needed in the hospital management of Acinetobacter baumannii colonizations-infections?]
    H Gbaguidi Haore
    Service d Hygiène Hospitalière et d Épidémiologie Moléculaire, Centre Hospitalier Universitaire Jean Minjoz, 2, Boulevard Fleming, 25030 Besancon Cedex, France
    Med Mal Infect 36:201-6. 2006
    ..These systematic isolation procedures were given up at the beginning of 2002 since the number of colonized-infected patients remained stable from 1998 to 2001...